|
MFHAS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.678310E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.232500E-02 |
| Normal-vs-Stage2 |
1.673710E-02 |
| Normal-vs-Stage3 |
7.944100E-03 |
| Normal-vs-Stage4 |
9.619600E-04 |
| Stage1-vs-Stage2 |
3.176200E-01 |
| Stage1-vs-Stage3 |
2.662000E-01 |
| Stage1-vs-Stage4 |
3.161800E-02 |
| Stage2-vs-Stage3 |
7.544400E-01 |
| Stage2-vs-Stage4 |
5.358600E-01 |
| Stage3-vs-Stage4 |
2.742400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.802000E-02 |
| Normal-vs-AfricanAmerican |
1.405050E-01 |
| Normal-vs-Asian |
4.141800E-02 |
| Caucasian-vs-AfricanAmerican |
8.576000E-01 |
| Caucasian-vs-Asian |
5.002000E-01 |
| AfricanAmerican-vs-Asian |
7.629600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.237300E-03 |
| Normal-vs-Female |
4.026400E-02 |
| Male-vs-Female |
1.699750E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.448560E-01 |
| Normal-vs-Age(41-60Yrs) |
1.275940E-02 |
| Normal-vs-Age(61-80Yrs) |
7.633100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.999770E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.590160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.350200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.124400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.946400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.296600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.597600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.111410E-01 |
| Classical-VS-Follicular |
1.76839987098276E-10 |
| Classical-VS-Other |
1.830050E-01 |
| Classical-VS-Normal |
2.844200E-01 |
| Tall-VS-Follicular |
8.062900E-03 |
| Tall-VS-Other |
3.448200E-01 |
| Tall-VS-Normal |
3.750500E-02 |
| Follicular-VS-Other |
6.440200E-01 |
| Follicular-VS-Normal |
1.59780000008602E-07 |
| Other-VS-Normal |
4.796000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.664700E-03 |
| Normal-vs-N1 |
7.360500E-03 |
| N0-vs-N1 |
7.142200E-01 |
|
|
